Bayer builds in Germany; Aventis splits from Novartis in vax venture;

> Bayer is investing $47 million in a facility in Wuppertal, Germany, to produce experimental biologics for its clinical trials. Release

> Sanofi-Aventis unit Aventis Pharma is selling its 49 percent stake in a vaccine-making company to partner Novartis. Story

> B2B trade board sellers are positioning themselves as drop shippers and order-fulfillment centers for Internet pharmacies. Release

> According to reports, Juhel Pharmaceutical Manufacturing's managing director Ifeanyi Okoye has been kidnapped in Anambra State, Nigeria, two months after the kidnapping of his mother. Article

> The Seoul Metropolitan Police have booked 15 pharmacists for importing fake Viagra from China. Story

> The Saudi Pharmaceutical Industry & Medical Appliances Corp. is one of several companies "leading the charge" to both import and produce pharmaceutical goods and equipment in the kingdom. Story

> Recovery from a decade-long economic contraction is driving growth in Zimbabwe's pharmaceutical sector. Release

> China's Lotus Pharmaceuticals is scrapping plans to build a facility in Inner Mongolia so it can focus on its core business in Beijing. Article

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.